
CPNG · NYSE
Consensus is Buy across 10 analysts, with a reported mean price target of $27.5. The supplied consensus does not provide low or high targets, so the target spread, the most bullish analyst, and the least bullish analyst cannot be identified. No analyst-specific revisions are reported during the past week, leaving the direction of target or rating changes undetermined. The substantive disagreement behind the valuation gap is also not disclosed in the evidence. The available debate is instead fundamental: Coupang has grown revenue from $30.3 billion in FY2024 to $34.5 billion in FY2025, but generated only $0.2 billion of net income in each year and reported a second-quarter loss despite a 65.39% earnings surprise.